News and Trends 4 Nov 2021 Skilled Labor Shortages Impact Cell And Gene Therapy Manufacturing …the solution. The cell and gene therapy fields enjoyed their best-ever funding yield in the first half of 2021, with €12.2B ($14.1B) netted globally. However, the biotech community is also… November 4, 2021 - 5 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Apr 2024 5 RNA editing companies you should know about …approximately $170 million, which is expected to provide cash runway through several milestones and into 2026. Wave Life Sciences Wave Life Sciences is committed to developing best-in-class therapies across multiple… April 18, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 12 May 2023 Cell and gene therapy company NewBiologix exits stealth with $50M …chronic conditions,” said NewBiologix co-founder and senior vice president of research and development, Nicolas Mermod, also a 20-year biotech veteran with expertise in molecular biotechnology. “NewBiologix’s platform is a quantum… May 12, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 12 Feb 2025 Dendritic cell therapy: Diakonos, Northwest Biotherapeutics and Mendus push ahead with next-generation candidates …lysate or mRNA),” explained Jay Hartenbach, president and chief operating officer (COO) of Diakonos Oncology, a biotech working on dendritic cell technology. “Once administered to the patient, these activated dendritic… February 12, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 26 Sep 2025 Can biotechnology reduce animal testing in medicine? …disease and treatments in question, a company must always show that its treatment is safe and effective in animal models to overcome regulatory hurdles. But with advances in biotechnology and… September 26, 2025 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 16 Nov 2022 Kadans Science Partner to develop new London life sciences innovation facility …and life science focused building, the largest in Europe, on the 3.3-hectare North Quay at Canary Wharf, which is expected to be ready in 2026. Ready in May 2023 Fit… November 16, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 8 Nov 2022 BC Platforms receives $20M financing …pharmaceutical companies, with more than 100 million accessible subjects by 2026. The financing will also accelerate the technology leadership of the company’s platform concerning data privacy, data harmonizing functionalities and… November 8, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 19 Mar 2025 Breast cancer treatments heat up: Five therapies poised to transform patient outcomes …the fourth consecutive year, demonstrating the interest in this indication from big pharma and biotech companies. In this article, we explore the overall breast cancer treatment landscape, with a particular… March 19, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 28 Aug 2024 GLP-1 shortage: Can biotech companies keep up with rising demand? …related health issues, has significantly outstripped the available supply and led to important shortages. How is the biotech industry responding to this shortage, and can supply really catch up with… August 28, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Startup Scout 19 Oct 2022 Neobe Therapeutics breaks down tumor defenses with bacteria …complete, the company will seek out investments to begin clinical trials by 2026. One of the challenges to building this new type of therapy is preventing the bacteria from triggering… October 19, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jun 2025 Beyond CRISPR: What CAST could bring to genome editing …should start in 2026. This means that approval of CAST-based therapeutics will not happen for at least 5 to 7 years,” said Fady Riad, chief executive officer (CEO) of Centurion… June 6, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 8 Jun 2022 United Therapeutics creates 3D printed lung scaffold …as three weeks using our latest advanced photopolymer-based bioprinting technology we call Print to Perfusion.” United Therapeutics United Therapeutics is the first publicly traded biotech or pharmaceutical company to take… June 8, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email